These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24626689)

  • 41. Multimedia education program and nutrition therapy improves HbA1c, weight, and lipid profile of patients with type 2 diabetes: a randomized clinical trial.
    Velázquez-López L; Muñoz-Torres AV; Medina-Bravo P; Vilchis-Gil J; Klϋnder-Klϋnder M; Escobedo-de la Peña J
    Endocrine; 2017 Nov; 58(2):236-245. PubMed ID: 28921414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population.
    Rodríguez-Rivera NS; Cuautle-Rodríguez P; Castillo-Nájera F; Molina-Guarneros JA
    Biomed Rep; 2017 Jul; 7(1):21-28. PubMed ID: 28685055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Modified Behavior Risk Factor Surveillance System to Assess Diabetes Self-management Behaviors and Diabetes Care in Monterrey Mexico: A Cross-sectional Study.
    McEwen MM; Elizondo-Pereo RA; Pasvogel AE; Meester I; Vargas-Villarreal J; González-Salazar F
    Front Public Health; 2017; 5():97. PubMed ID: 28512629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The panorama of familial hypercholesterolemia in Latin America: a systematic review.
    Mehta R; Zubirán R; Martagón AJ; Vazquez-Cárdenas A; Segura-Kato Y; Tusié-Luna MT; Aguilar-Salinas CA
    J Lipid Res; 2016 Dec; 57(12):2115-2129. PubMed ID: 27777316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).
    Lugo-Palacios DG; Cairns J; Masetto C
    BMC Health Serv Res; 2016 Aug; 16():333. PubMed ID: 27484124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes and hypertension care among male prisoners in Mexico City: exploring transition of care and the equivalence principle.
    Silverman-Retana O; Servan-Mori E; Lopez-Ridaura R; Bautista-Arredondo S
    Int J Public Health; 2016 Jul; 61(6):651-659. PubMed ID: 27094508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Perception of insulin therapy in uncontrolled patients with type 2 diabetes mellitus].
    Leyva Jiménez R; Hernández Zambrano G; Ibarra Maldonado S; Ibarra Ramírez CT
    Aten Primaria; 2016 Oct; 48(8):543-549. PubMed ID: 26921975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers.
    Figueroa-Lara A; Gonzalez-Block MA; Alarcon-Irigoyen J
    PLoS One; 2016; 11(1):e0145177. PubMed ID: 26744844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Social Support of Patients with Type 2 Diabetes in Marginalized Contexts in Mexico and Its Relation to Compliance with Treatment: A Sociocultural Approach.
    Juárez-Ramírez C; Théodore FL; Villalobos A; Jiménez-Corona A; Lerin S; Nigenda G; Lewis S
    PLoS One; 2015; 10(11):e0141766. PubMed ID: 26545122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of Diabetes Care: The Challenges of an Increasing Epidemic in Mexico. Results from Two National Health Surveys (2006 and 2012).
    Flores-Hernández S; Saturno-Hernández PJ; Reyes-Morales H; Barrientos-Gutiérrez T; Villalpando S; Hernández-Ávila M
    PLoS One; 2015; 10(7):e0133958. PubMed ID: 26230991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women.
    Huerta-Chagoya A; Vázquez-Cárdenas P; Moreno-Macías H; Tapia-Maruri L; Rodríguez-Guillén R; López-Vite E; García-Escalante G; Escobedo-Aguirre F; Parra-Covarrubias A; Cordero-Brieño R; Manzo-Carrillo L; Zacarías-Castillo R; Vargas-García C; Aguilar-Salinas C; Tusié-Luna T
    PLoS One; 2015; 10(5):e0126408. PubMed ID: 25973943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding the development and prevention of type 2 diabetes in youth (part 1).
    Berry D; Urban A; Grey M
    J Pediatr Health Care; 2006; 20(1):3-10. PubMed ID: 16399474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Type 2 diabetes and frecuency of prevention and control measures].
    Jiménez-Corona A; Aguilar-Salinas CA; Rojas-Martínez R; Hernández-Ávila M
    Salud Publica Mex; 2013; 55 Suppl 2():S137-43. PubMed ID: 24626689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UISESS scale for staging and classifying clinical-epidemiological risk in type 2 diabetes mellitus and for establishing multidisciplinary preventive actions.
    García de Alba JE; Salcedo Rocha AL; Colunga Rodríguez C; González Barrera JA; Herrera Solís E; Milke Najar ME
    Prev Med; 2005 Jul; 41(1):211-8. PubMed ID: 15917013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study.
    Martins RB; Ordaz-Briseño SA; Flores-Hernández S; Bós ÂJG; Baptista-Rosas RC; Mercado-Sesma AR
    BMC Endocr Disord; 2021 Mar; 21(1):48. PubMed ID: 33726717
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.